Utah Medical Products (UTMD) Retained Earnings (2010 - 2026)

Utah Medical Products' Retained Earnings history runs 17 years deep, the most recent figure standing at $130.3 million for Q1 2026.

• On a quarterly basis, Retained Earnings rose 1.6% year-over-year to $130.3 million in Q1 2026; TTM through Mar 2026 was $130.3 million, a 1.6% increase from a year earlier, with the FY2025 full-year figure at $128.7 million, down 0.5% from the prior year.
• Retained Earnings rose to $130.3 million in Q1 2026 per UTMD's latest filing, from $128.7 million in the prior quarter.
• Across five years, Retained Earnings topped out at $139.0 million in Q1 2024 and bottomed at $117.8 million in Q1 2022.
• The 5-year median for Retained Earnings is $129.2 million (2023), against an average of $129.4 million.
• Across the five-year window, Retained Earnings advanced 10.89% in 2023 and retreated 7.76% in 2025, its largest moves.
• Year by year, Retained Earnings stood at $126.0 million in 2022, then grew by 9.79% to $138.3 million in 2023, then dropped by 6.53% to $129.3 million in 2024, then fell by 0.5% to $128.7 million in 2025, then advanced by 1.25% to $130.3 million in 2026.
• Per Business Quant, the three latest UTMD Retained Earnings figures stand at $130.3 million (Q1 2026), $128.7 million (Q4 2025), and $128.0 million (Q3 2025).